Literature DB >> 18300053

Paul Ehrlich: the Nobel Prize in physiology or medicine 1908.

Anna Piro1, Antonio Tagarelli, Giuseppe Tagarelli, Paolo Lagonia, Aldo Quattrone.   

Abstract

We wish to commemorate Paul Ehrlich on the centennial of his being awarded the Nobel Prize in Physiology or Medicine in 1908. His studies are now considered as milestones in immunology: the morphology of leukocytes; his side-chain theory where he defined the cellular receptor for first time; and his clarification of the difference between serum therapy and chemotherapy. Ehrlich also invented the first chemotherapeutic drug: compound 606, or Salvarsan. We have used some original documents from the Royal Society of London, where Ehrlich was a fellow, and from Leipzig University, where he took a degree in medicine.

Entities:  

Mesh:

Year:  2008        PMID: 18300053     DOI: 10.1080/08830180701848995

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  3 in total

Review 1.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

2.  Kudos to the virus hunters.

Authors:  Bc Mathew; Rs Daniel; J Bordom
Journal:  Libyan J Med       Date:  2009-03-01       Impact factor: 1.657

Review 3.  Role of Leukotriene B4 Receptor-2 in Mast Cells in Allergic Airway Inflammation.

Authors:  Sun-Young Kwon; Jae-Hong Kim
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.